Surgical Science Sweden AB (SUS) — Cash Flow Reinvestment Rate
Surgical Science Sweden AB (SUS) has a Cash Flow Reinvestment Rate of 0.09x as of December 2025, reinvesting Skr6.24 Million (capex Skr6.24 Million ) from operating cash flow of Skr72.89 Million. Check SUS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Surgical Science Sweden AB Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Surgical Science Sweden AB across 11 annual periods. Explore SUS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Surgical Science Sweden AB (2015–2025)
Year-by-year capital reinvestment analysis for Surgical Science Sweden AB. For live market cap and broader valuation context, see Surgical Science Sweden AB (SUS) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.15x | Skr11.68 Million | Skr79.80 Million | Skr11.68 Million | ▼ -78.9% |
| 2024 | 0.69x | Skr95.06 Million | Skr137.22 Million | Skr47.53 Million | ▲ +87.0% |
| 2023 | 0.37x | Skr88.26 Million | Skr238.29 Million | Skr44.13 Million | ▼ -30.6% |
| 2022 | 0.53x | Skr69.10 Million | Skr129.49 Million | Skr34.55 Million | ▼ -99.2% |
| 2021 | 70.29x | Skr2.75 Billion | Skr39.08 Million | Skr14.38 Million | ▲ +9288.1% |
| 2020 | 0.75x | Skr17.39 Million | Skr23.23 Million | Skr8.69 Million | ▼ -81.1% |
| 2019 | 3.97x | Skr219.22 Million | Skr55.20 Million | Skr8.91 Million | ▲ +58.1% |
| 2018 | 2.51x | Skr17.27 Million | Skr6.88 Million | Skr8.64 Million | ▼ -17.7% |
| 2017 | 3.05x | Skr24.23 Million | Skr7.94 Million | Skr12.12 Million | ▲ +249.7% |
| 2016 | 0.87x | Skr11.70 Million | Skr13.40 Million | Skr11.70 Million | ▼ -21.1% |
| 2015 | 1.11x | Skr8.30 Million | Skr7.50 Million | Skr8.30 Million | — |